{"news_desk": "Editorial", "print_page": "20", "section_name": "Opinion", "subsection_name": null, "byline": {"original": "By THE EDITORIAL BOARD", "person": [], "organization": "THE EDITORIAL BOARD"}, "abstract": "Editorial applauds Federal Trade Commission and state officials like New York Atty Gen Eric Schneiderman for vigilant oversight of drug manufacturers using underhanded tactics; notes manufacturers of brand-name drugs were trying to ward off competition from less expensive generic drugs in order to continue high levels of profit on pharmaceuticals; holds consumers and insurers deserve full access to safe, effective and far less costly generic equivalents.", "type_of_material": "Editorial", "word_count": "485", "lead_paragraph": "Vigilant oversight is needed to prevent drug companies from buying off competitors or forcing switches to newer drugs.", "pub_date": "2015-06-08T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Sneaky Ways to Raise Drug Profits", "content_kicker": "Editorial", "print_headline": "Sneaky Ways to Raise Drug Profits", "kicker": "Editorial"}, "snippet": "Vigilant oversight is needed to prevent drug companies from buying off competitors or forcing switches to newer drugs.", "multimedia": [{"height": 126, "url": "images/2015/06/06/opinion/08mon2web/08mon2web-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/06/06/opinion/08mon2web/08mon2web-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/06/06/opinion/08mon2web/08mon2web-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/06/06/opinion/08mon2web/08mon2web-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/06/06/opinion/08mon2web/08mon2web-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/06/06/opinion/08mon2web/08mon2web-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/06/08/opinion/sneaky-ways-to-raise-drug-profits.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Editorials", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Generic Brands and Products", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Federal Trade Commission", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Schneiderman, Eric T", "name": "persons"}, {"rank": "5", "is_major": "Y", "value": "Attorneys General", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Cephalon Inc", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Actavis PLC", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "9", "is_major": "N", "value": "Regulation and Deregulation of Industry", "name": "subject"}, {"rank": "10", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "5575427338f0d8502adcc2c5", "source": "The New York Times"}